BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Phase II (World)
Galapagos NV (GLPG.BR) Release: GSK2586184 Met Primary Endpoint In Phase 2a Psoriasis Study 4/17/2014  More...
Final Data From The Phase 2 COSMOS Study Of Janssen Research & Development's Once-Daily Simeprevir In Combination With Sofosbuvir Presented At The International Liver Congress™ 2014 Of The European Association For The Study Of The Liver (EASL) 4/14/2014  More...
Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study 4/14/2014  More...
GenKyoTex S.A. 's GKT137831 Found To Reverse Fibrosis And Improve Survival In A Model Of Persistent Lung Fibrosis 4/10/2014  More...
Gilead Sciences, Inc. (GILD) Announces Phase 2 Results For Two Investigational All-Oral Sofosbuvir-Based Regimens For The Treatment Of Chronic Hepatitis C 4/10/2014  More...
BioLineRx Ltd. Announces Investigator-Initiated Study For Novel Chronic Myeloid Leukemia Treatment 4/10/2014  More...
Alcobra (ADHD) Submits Protocol To FDA For Phase 2b Clinical Study Of Metadoxine Extended Release (MDX) In The Treatment Of Fragile X Syndrome 4/10/2014  More...
Adocia Reports Positive Results From Phase 2a Clinical Study Of Ultra-Fast Acting Biochaperone® Lispro 4/9/2014  More...
NOXXON Pharma AG Release: Anti-Hepcidin Spiegelmer® Lexaptepid Pegol Increases Hemoglobin In Subset Of Anemic Patients In Pilot Phase 2a Study 4/8/2014  More...
Mologen AG (MOLGF.PK): DSLIM® Shows Superior Immunoactivation Capabilities 4/8/2014  More...
Viralytics Ltd (VLA.AX) Release: Positive Interim Phase 2 Trial Results For CAVATAK™, Novel Cancer Immunotherapy 4/8/2014  More...
Pfizer Inc. (PFE) Continues Its Streak, Phase 2 Breast Cancer Results Wows Investors And Researchers 4/8/2014  More...
Alnylam Pharmaceuticals (ALNY) Receives Positive Opinion For Orphan Drug Designation In The European Union For ALN-Ttrsc, A Subcutaneously Delivered Rnai Therapeutic For The Treatment Of Transthyretin-Mediated Amyloidosis (ATTR) 4/2/2014  More...
PRANA Biotechnology (PRAN) Tanks As Lead Drug Fails Alzheimer's Study 4/1/2014  More...
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Tout Positive Phase 2b Bipolar Depression Data 3/31/2014  More...
Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus 3/31/2014  More...
Novartis AG (NVS)'s Rare Lung Cancer Drug Ceritinib Shows Positive Response In Study 3/27/2014  More...
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Shows Off Positive Phase 2b Data For Cariprazine To Treat Depression 3/21/2014  More...
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Recruitment Completed 3/21/2014  More...
Bionomics Limited (BNO.AX) Sinks As Renal Cancer Drug Fails Key Phase 2 Test 3/19/2014  More...
Ipsen (IPN.PA): Dysport Incontinence Treatment Phase 2a Trial Positive 3/18/2014  More...
Pharma Two B Ltd. Commences Phase 2b Study Of Fixed Dose Combination Therapy “P2B001” For Parkinson’s Disease 3/18/2014  More...
Asthma Leader GlaxoSmithKline (GSK) Faces Competition From Roche (RHHBY), AstraZeneca PLC (AZN), Sanofi (France) (SAN.PA), And Teva Pharmaceutical Industries Limited (TEVA) 3/18/2014  More...
Can-Fite BioPharma (CFBI): Phase II Study Protocol To Treat Patients With Advanced Liver Cancer With CF102 Has Been Approved By The IRB In Israel 3/17/2014  More...
Neovacs SA Announces Positive IDSMB Review Of The Phase 2b Study Of TNF-Kinoid In Rheumatoid Arthritis 3/12/2014  More...
ALK-Abello A/S’s Partner For Japan Reports Positive Trial Results For House Dust Mite SLIT-Tablet 3/10/2014  More...
Edison Pharmaceuticals, Inc. Announces Initiation Of EPI-743 Phase 2B/3 Leigh Syndrome Clinical Trial With Dainippon Sumitomo Pharma Co., Ltd. In Japan 3/10/2014  More...
Roche (RHHBY) Drug Cuts Asthma Attacks, Improves Lung Function In Phase 2b Study 3/6/2014  More...
Medivir AB (MVRBF) Release: SVR12 Results From A Phase 2a Study Evaluating Simeprevir And Daclatasvir In Hepatitis C Patients Of Genotype 1 Have Been Presented 3/5/2014  More...
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Anti-Inflammatory Drug Pact Hits A Roadblock 3/4/2014  More...
D-Pharm Ltd. Reports The Successful Interim Analysis Of Its Phase 2 Clinical Study Of THR-18 In Acute Stroke Patients Treated With The Thrombolytic Drug tPA 3/4/2014  More...
Kamada Ltd. (KMDA.TA) Completes Enrollment In U.S. Pivotal Clinical Trial With Kamrab As A Post-Exposure Treatment For Rabies 3/4/2014  More...
Genticel Reaches An Important Milestone By Launching Its Phase II Trial In Women Infected With High-Risk HPV Before The Appearance Of High Grade Cervical Lesions 3/4/2014  More...
Atopix Shows Off Positive Phase 2b Results For Once Daily OC459 In Asthma 3/3/2014  More...
Novartis AG (NVS)'s Experimental Skin Cancer Drug Meets Primary Endpoint In Pivotal Phase 2 Trial 2/21/2014  More...
PRANA Biotechnology (PRAN) Soars As Brain Disorder Drug Succeeds In Phase 2 Trial; Stock Up +39.31% At Market Close (February 18, 2014) 2/19/2014  More...
Galapagos NV (GLPG.BR) Completes Patient Recruitment In Proof Of Concept Study With GLPG0974 In Ulcerative Colitis 2/18/2014  More...
Galapagos NV (GLPG.BR) Completes Patient Recruitment In Proof Of Concept Study With GLPG0974 In Ulcerative Colitis 2/17/2014  More...
Ario Pharma Commences Phase 2a Trial Of TRPV1 Inhibitor For Cough Associated With Chronic Obstructive Pulmonary Disease 2/11/2014  More...
Oramed Pharmaceuticals Inc. (ORMP) Submits Phase 2a Protocol To FDA For The Treatment Of Type 1 Diabetes With Its Oral Insulin Capsule 2/10/2014  More...
AstraZeneca PLC (AZN) Takes On Merck & Co., Inc. (MRK) In Alzheimer's Drug Race 2/7/2014  More...
Can-Fite BioPharma (CFBI) Submitted Phase II Study Protocol With CF102 To Treat Patients With Advanced Liver Cancer 2/6/2014  More...
Targovax TG01 Immunotherapy Reaches Phase 2a In Operable Pancreatic Cancer 2/6/2014  More...
Spinifex Pharmaceuticals ' Phase 2 Results Published In The Lancet Show EMA401 To Be Effective In Reducing Pain In Postherpetic Neuralgia 2/5/2014  More...
Oramed Pharmaceuticals Inc. (ORMP) Announces Successful FDA Phase 2a Clinical Trial Results 1/30/2014  More...
Galapagos NV (GLPG.BR) Release: First Clinical Centers Opened For Phase 2 Crohn's Study With GLPG0634 1/30/2014  More...
Positive Spinal Disc Repair Trial Results Using Mesoblast Limited (MSB.AX) Adult Stem Cells 1/30/2014  More...
Allergy Therapeutics plc: Short Course Immunotherapy Effective In Reducing Ragweed Pollen Allergy 1/27/2014  More...
Prosonix Reports Positive Top-Line Results From Its Phase 2 Clinical Study With PSX1002 In Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) 1/23/2014  More...
BioLineRx Ltd. Receives Orphan Drug Designation For Novel Stem Cell Mobilization Treatment 1/23/2014  More...
D-Pharm Ltd. Completes Recruitment Of Patients Into The First Dosage Tier Of Its Phase 2 Study With THR-18 In Acute Stroke Patients Treated With tPA. 1/21/2014  More...
Prima Biomed (PRR.AX) Revised CAN-004 Trial Of Cvact In Ovarian Cancer Approved In Belgium - First Regulator To Approve Amended CVact Clinical Trial Design 1/20/2014  More...
ERYtech Pharma Announces Clinical Trial Authorizations In Finland And Spain For Its European Phase 2b Study In AML 1/15/2014  More...
D-Pharm Ltd. Announces Recruitment Of The First Patient Into Its Phase 2 Clinical Trial With DP-B99 In Acute High-Risk Pancreatitis 1/14/2014  More...
GlaxoSmithKline (GSK)'s Tafinlar Drug Gets FDA Breakthrough Therapy Designation 1/14/2014  More...
Apogenix' APG101 Demonstrates Significant Prolongation Of Overall Survival In Biomarker-Positive Patients In Phase II Trial For The Treatment Of Recurrent Glioblastoma 1/13/2014  More...
Medivir AB (MVRBF) Release: Interim Results (SVR4) From A Phase 2 All-Oral Combination Study Of Simeprevir And Samatasvir (IDX719) For The Treatment Of Hepatitis C 1/13/2014  More...
EntreMed, Inc. (ENMD) Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA 1/13/2014  More...
Dezima Pharma Completes Patient Enrollment For TULIP Phase 2B Study With CETP Inhibitor TA-8995 1/13/2014  More...
TRANSGENE (ENX:TNG) Announces Topline Preliminary Results From Phase 2b Part Of TIME Trial With TG4010 In Non-Small Cell Lung Cancer 1/9/2014  More...
Positive Feedback From The Scientific Community For Anaconda Pharma's Phase 2a Data For AP611074 First Clinical Proof Of Concept For The Curative Treatment Of Condyloma 1/9/2014  More...
Viralytics Ltd (VLA.AX) Release: Target Enrollment Achieved In CAVATAK™ USA Phase 2 Melanoma Trial With Excellent Interim Results 1/8/2014  More...
Adocia Launches Phase 2a Clinical Trial For Its Ultra-Fast Acting Formulation Of Analog Insulin 1/6/2014  More...
D-Pharm Ltd. Reports Enrollment Of First Patient Into Phase 2 Study Of THR-18 In Stroke Patients Treated With Tissue Plasminogen Activator (tPA) 1/2/2014  More...
Cerenis Therapeutics, Inc.'s Cholesterol Drug CER-001 Fails In Mid-Stage Trial 1/2/2014  More...
Axelar AB's Phase 2 Lung Cancer Study Data Does Not Impress 12/31/2013  More...
Antisense Therapeutics Limited (ANP.AX) Release: Positive Results Achieved From Interim Analysis Of ATL1103 Phase II Trial 12/23/2013  More...
BioSpecifics Technologies Corporation (BSTC) Announces Top-Line Data From Phase 2 Trial Of CCH For Canine Lipoma 12/23/2013  More...
Can-Fite BioPharma (CFBI) Soars On Positive Phase 2 Rheumatoid Arthritis Study; Stock Up +19.23% At Market Close (Dec. 23, 2013) 12/23/2013  More...
GlaxoSmithKline (GSK)'s Malaria Drug Wins FDA "Breakthrough" Status 12/23/2013  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Announces Successful Results From Ex-US Pharmacokinetic Study Of Its Oral Insulin For The Treatment Of Type 1 Diabetes 12/20/2013  More...
MicuRx Pharmaceuticals Expands Global Clinical Trial Program For Oral Antibiotic MRX-I 12/20/2013  More...
Alcobra (ADHD) Release: FDA Grants Orphan Drug Status To Metadoxine In Fragile X Syndrome 12/19/2013  More...
Octapharma AG Phase 2/3 Trial For The Targeted Treatment Of Relapsing Multiple Sclerosis Enrols First Patients 12/18/2013  More...
NovaBiotics Ltd Initiates Development Of Orphan Drug In Cystic Fibrosis 12/17/2013  More...
Biomay AG Successfully Completes Interim Analysis Of Phase 2 Study With The Innovative 3rd Generation Grass Pollen Allergy Vaccine BM32 12/16/2013  More...
Alcobra (ADHD) Announces Highly Statistically Significant Positive Phase 2b Clinical Trial Results In Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder 12/16/2013  More...
BioLineRx Ltd. Announces Promising Initial Phase 2 Results Of Acute Myeloid Leukemia Treatment 12/16/2013  More...
Medivir AB (MVRBF) Release: An All-Oral Phase 2a Study Combining Simeprevir, TMC647055 And JNJ56914845 In Hepatitis C Patients To Be Initiated 12/12/2013  More...
Targeted Antibody, Immune Checkpoint Blocker Rein In Follicular Lymphoma 12/12/2013  More...
Kamada Ltd. (KMDA.TA) Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency 12/11/2013  More...
Preliminary Findings Of BrainStorm Cell Therapeutics Inc.'s Phase 2a Study Reported As "Extremely Optimistic" 12/10/2013  More...
NOXXON Pharma AG Release: Interim Phase 2a Results For Spiegelmer® Olaptesed Pegol (NOX-A12) In CLL And MM Studies 12/9/2013  More...
NOXXON Pharma AG Release: Interim Phase IIa Results For Spiegelmer Olaptesed Pegol (NOX-A12) In CLL And MM Studies 12/9/2013  More...
Neovacs SA Succesfully Enrolls First Patients In Its Phase 2b Study Of Tnf-Kinoid For The Treatment Of Rheumatoid Arthritis 12/9/2013  More...
Can-Fite BioPharma (CFBI) Anticipates Results From Two Clinical Trials 12/5/2013  More...
Apogenix' APG350 Effectively Induces Apoptosis Of Tumor Cells Via TRAIL Pathway Independent Of Fc-gamma Cross-Linking 12/5/2013  More...
Mesoblast Limited (MSB.AX) Reports Positive Type 2 Diabetes Trial Results 12/4/2013  More...
InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used In Combination With Standard Antiretroviral Therapy In Treatment Of HIV-Infection 12/2/2013  More...
Galapagos NV (GLPG.BR) Announces GSK2586184 JAK1 Molecule Moves Into Phase 2 For Ulcerative Colitis 11/27/2013  More...
Bone Therapeutics Treats First Patients In PREOB® Pivotal Phase IIb/III Trial For The Treatment Of Non-Union Fractures 11/26/2013  More...
BioLineRx Ltd. Announces New Positive Results In Phase 2a Trial For Orally Available Inflammatory Bowel Disease Treatment 11/26/2013  More...
Alcobra (ADHD) Announces New Findings On Diminished Abuse Potential Of Its Proprietary Drug Candidate, MG01CI 11/22/2013  More...
Zealand Pharma  (ZEAL.CO) Advances Danegaptide, Its Novel Drug Candidate, Into A Phase 2 Clinical Proof-Of-Concept Study For Protection Against Reperfusion Injury In Patients With Myocardial Infarction 11/20/2013  More...
Pluristem Therapeutics (PSTI) Receives Regulatory Approval To Extend Its Phase II Study of PLX-PAD Cells In The Treatment Of Intermittent Claudication To South Korea 11/13/2013  More...
PsiOxus Therapeutics Limited Cancer-Wasting Drug Better Than Placebo In Phase 2 Study 11/13/2013  More...
Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich 11/11/2013  More...
ERYtech Pharma Announces Positive DSMB Review Of Its Phase 2b Study In Acute Myeloid Leukemia 11/11/2013  More...
GenKyoTex S.A. NOX Inhibitor GKT137831 Successfully Shown To Halt Diabetic Kidney Disease 11/11/2013  More...
Amakem NV to Present Top-Line Clinical Results for its Lead Candidate, AMA0076, at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Meeting 2013 11/7/2013  More...
Shanghai Sundise Reports Positive Results From TCM Liver Fibrosis Trial 11/7/2013  More...
Trophos Completes Pivotal Phase II/III Study of Olesoxime in Spinal Muscular Atrophy (SMA) 11/6/2013  More...
Medivir AB (MVRBF) Release: Results From the COSMOS Study With Simeprevir and Sofosbuvir in Cirrhotic and Non-Cirrhotic HCV genotype 1 Patients Presented at American Association for Study of Liver Diseases 11/5/2013  More...
AB Science (AB.PA) Release: Masitinib is Being Investigated in the Treatment of Amyotrophic Lateral Sclerosis (ALS) 11/5/2013  More...
Serodus AS Enrolls First Patient in SER100 Phase 2a Isolated Systolic Hypertension Clinical Study 11/5/2013  More...
Active Biotech AB (BTPC)'s Partner Teva Pharmaceutical Industries Limited (TEVA) Initiates a Further Clinical Trial in Multiple Sclerosis 11/4/2013  More...
Alfact Innovation Announces Positive Clinical Trial Results for Treatment of AIH- and HBV- Related Acute-on-Chronic Liver Diseases 11/4/2013  More...
GeNeuro Successfully Completes Phase 2a Clinical Study With Novel Approach to Treat Multiple Sclerosis 11/4/2013  More...
Immunocore Limited Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma 10/31/2013  More...
PRANA Biotechnology (PRAN)'s PBT2 Reverses Memory Loss in Normal Aging 10/31/2013  More...
Anaconda Pharma: Scientific Breakthrough in HPV Treatment 10/31/2013  More...
e-Therapeutics plc Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder 10/31/2013  More...
Addex Therapeutics (ADXN.SW) Licensee Completes Enrollment of 120 Patients in a Phase 2 Clinical Trial of ADX71149 for the Treatment of Anxious Depression 10/29/2013  More...
Alexion Pharmaceuticals Inc. (ALXN) Scores Another Breakthrough Designation for Ultra-Rare Metabolic Disorder 10/29/2013  More...
GENFIT Corp. (ALGFT) Release: GFT505: the DSMB Approves the Continuation of the Phase 2b Study in NASH 10/28/2013  More...
National Institutes of Health (NIH)-Sponsored Consortium of Food Allergy Research (CoFAR) Starts a Phase 2 Clinical Study With DBV Technologies' Viaskin® Peanut in the Treatment of Peanut Allergy 10/24/2013  More...
Immunology Data Further Underline the Positive Outcome of a Phase IIb Trial of Anergis' Birch Pollen Allergy Vaccine AllerT 10/21/2013  More...
GANYMED Pharmaceuticals AG's IMAB362 Receives Orphan Drug Designation From FDA and European Medicines Agency for Pancreatic Cancer 10/21/2013  More...
D-Pharm Ltd. Commences Phase 2 Study With THR-18 in Stroke Patients Treated With Tissue Plasminogen Activator (tPA) 10/16/2013  More...
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Positive Results From Its Phase 2 Clinical Study of E-58425 in Acute Pain 10/16/2013  More...
PledPharma Release: The Sixth Patient in the First Part of the PLIANT-Study Approved for Continued Dosing 10/15/2013  More...
Acacia Pharma Announces Positive Phase 2 Results With APD515 for Xerostomia in Advanced Cancer 10/15/2013  More...
Genmab A/S (GEN.CO) Touts Positive Phase 2 Results for Multiple Sclerosis Drug 10/14/2013  More...
Alkermes plc (ALKS) Announces Alignment With FDA on Plans for Pivotal Program for ALKS 5461 for Major Depressive Disorder 10/9/2013  More...
Kiadis Pharma Secures Manufacturing Services Agreement for Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ With the German Red Cross Blood Donor Service 10/7/2013  More...
New Data Show Novartis AG (NVS)' Gilenya® Reduced Brain Volume Loss in MS Patients 10/7/2013  More...
Positive Results Presented from Proof-of-Concept Phase II Clinical Trial of Incyte Corporation (INCY)'s Oral JAK1 Inhibitor in Patients With Chronic Plaque Psoriasis 10/3/2013  More...
Pluristem Therapeutics (PSTI) Receives Israeli Ministry of Health Approval to Expand Its Phase 2 Clinical Trial in Intermittent Claudication to Israel 10/2/2013  More...
MorphoSys AG Collaborator to Start Pivotal Study With Bimagrumab 10/2/2013  More...
Trophos Announces Final Patient Completion of Phase II Proof-of-Concept Study of TRO40303 in Patients Treated for Acute Myocardial Infarction 10/2/2013  More...
Circassia Limited's Grass Allergy Treatment Achieves Significant Symptom Reduction During Hay Fever Season 10/1/2013  More...
Prima Biomed (PRR.AX) Management Presentation of CVAC™ Phase 2 Trial Results 10/1/2013  More...
BrainStorm Cell Therapeutics Inc. Launches US Activities for Its Multi-Center ALS Clinical Trial 10/1/2013  More...
BioAlliance Pharma First Meeting of the International Advisory Board on Oral Mucositis and Development of Validive® 9/30/2013  More...
Mesoblast Limited's Phase 2 Trial For Lumbar Spinal Fusion Selected For Presentation at Premier Spine Conference 9/19/2013  More...
Prima Biomed (PRR.AX)'s Ovarian Cancer Treatment Shows No Difference in Phase 2 Study 9/19/2013  More...
Viralytics Ltd (VLA.AX) Meets Primary Endpoint in CAVATAK Phase 2 Melanoma Trial 9/18/2013  More...
FDA Lifts Clinical Hold of Pluristem Therapeutics (PSTI)'s Phase 2 Intermittent Claudication Study 9/16/2013  More...
Can-Fite BioPharma's Level II ADRs Commence Trading on the U.S. OTC Markets 9/13/2013  More...
PRANA Biotechnology (PRAN) Updates Progress on PBT2 Trials in Alzheimer's and Huntington's Diseases 9/13/2013  More...
Circassia Limited's Short-Course House Dust Mite Allergy Treatment Achieves Significant Long-Term Symptom Reduction 9/12/2013  More...
CANbridge Life Sciences Enters Into Agreement With Azaya Therapeutics, Inc. to Develop ATI-1123 for Lung Cancer in China and North Asia 9/11/2013  More...
Genmab A/S (GEN.CO) Announces New Study of Daratumumab in Double Refractory Multiple Myeloma 9/10/2013  More...
Second Phase II Clinical Trial Confirms Safety and Efficacy Trends for Auris Medical AG's AM-101 in Treatment of Acute Peripheral Tinnitus 9/9/2013  More...
Afferent Pharmaceuticals Reports Positive Phase 2 Clinical Data for the Company’s Lead P2X3 Antagonist, AF-219 9/9/2013  More...
AstraZeneca PLC (AZN) Reverses $285 Million Charge as Cancer Trial Starts 9/5/2013  More...
Elan Corporation PLC (ELN) Announces Dosing of First Patient in Phase 2a Trial of ELND005 (Scyllo-inositol) in Down Syndrome 9/4/2013  More...
DBV Technologies Initiates a Long-Term Follow-Up Study of Viaskin Peanut 9/4/2013  More...
TRANSGENE (ENX:TNG)'s TRAVERSE Phase 2 Study Fails to Meet Main Goal 9/4/2013  More...
Jennerex, Inc. Announces That Its Phase 2 Study of Pexa-Vec in Second-Line Advanced Liver Cancer Did Not Meet Its Primary Endpoint 9/4/2013  More...
Isis Pharmaceuticals, Inc. (ISIS)'s Experimental Heart Drug Leads to Big Reduction in Blood Fat in Phase 2 Study; Stock Up +3.48% at Market Close (September 3, 2013) 9/4/2013  More...
Apitope Announces Positive Results From Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis 9/3/2013  More...
Dezima Pharma Initiates Phase 2b TULIP Study on CETP Inhibitor Program DEZ-001 8/29/2013  More...
Roche (RHHBY) Looks to Replicate Cancer Success With Eye Drugs 8/29/2013  More...
Medivir AB (MVIRb.F) Announces Interim Results From Cohort 2 of the COSMOS Study Evaluating Simeprevir and Sofosbuvir in HCV Patients With METAVIR Scores F3-F4 8/28/2013  More...
Orexo AB Reports Successful Completion of OX51 Phase II Dose-Finding Study in Prevention of Procedure-Induced Pain 8/28/2013  More...
Can-Fite BioPharma to Initiate a Phase II Study With CF102 in 130 Patients With Advanced Liver Cancer 8/28/2013  More...
PharmaEngine, Inc. Release: Studies of Nanoliposomal Irinotecan (PEP02, MM-398) in Late Stage Pancreatic Cancer and Gastric Cancer Published in British Journal of Cancer and Annals of Oncology 8/28/2013  More...
Medivir AB (MVIRb.F) Announces Interim Results From Cohort 2 of the COSMOS Study Evaluating Simeprevir and Sofosbuvir in HCV Patients With METAVIR Scores F3-F4 8/28/2013  More...
Orexo AB Reports Successful Completion of OX51 Phase II Dose-Finding Study in Prevention of Procedure-Induced Pain 8/28/2013  More...
Oncolytic Virus Specialist Virttu Biologics Confirms Treatment of First Cohort of Patients in Phase I/II SEPREHVIR® Study in Mesothelioma 8/26/2013  More...
FDA Grants "Breakthrough Status" to Novartis AG (NVS)'s Muscle Wasting Drug 8/22/2013  More...
Prima Biomed (PRR.AX)'s "CANVAS" Clinical Trial Approved to Start in Korea 8/14/2013  More...
BrainStorm Cell Therapeutics Inc. Submits Favorable Interim Safety Report for Second Group of Patients in Its Phase IIa Dose-Escalating Trial of NurOwn™ in ALS 8/1/2013  More...
PRANA Biotechnology (PRAN) Prepares for Next Steps in the PBT2 Development Path to Market and Commercialization With Key Appointments Strategy 8/1/2013  More...
Karolinska Development AB: Pharmanest Meets All Efficacy and Safety End Points in Phase II Study of SHACT 8/1/2013  More...
Pharmanest Meets All Efficacy and Safety End Points in Phase II Study of SHACT 8/1/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces Positive Pre-Clinical Rheumatoid Arthritis Results With RHB-104 and Plans for a Phase IIa Study 7/30/2013  More...
BrainStorm Cell Therapeutics Inc.'s NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS 7/29/2013  More...
NOXXON Pharma AG Completes Patient Recruitment for Phase 2 Study in Diabetic Nephropathy 7/24/2013  More...
PRANA Biotechnology (PRAN) Completes Phase 2 Huntington Disease Trial With PBT2 7/23/2013  More...
Invion Limited Announces Commencement of Phase 2 Chronic Bronchitis Clinical Trial 7/22/2013  More...
Pot-Based Diabetes Drug Maker GW Pharmaceuticals Sees Slowing of Illness 7/19/2013  More...
Invion Limited Announces Commencement of Phase 2 Clinical Trial in Lupus 7/19/2013  More...
FDA Grant Fast Track Designation to Elan Corporation PLC (ELN)'s ELND005 for the Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease 7/17/2013  More...
Alkermes plc (ALKS) Announces Initiation of Phase 2 Clinical Study of ALKS 3831, Designed to be a Broad Spectrum Oral Antipsychotic for the Treatment of Schizophrenia 7/17/2013  More...
Lundbeck Inc. (LUN.CO) and Otsuka Pharmaceutical Co., Ltd. Release: Phase II Clinical Data Show Statistically Sgnificant Improvement for Lu AE58054 as Addon to Donepezil, Versus donepezil Alone, on Cognitive Symptoms of Alzheimer's Disease 7/17/2013  More...
Study Demonstrating Pancreatic Islet Xenograft Survival With Kamada Ltd. (KMDA.TA)'s AAT Published in Peer-Reviewed Publication 7/10/2013  More...
Prima Biomed (PRR.AX) Activates Study Sites in Germany and Multiple European Countries for "CANVAS" Clinical Trial 7/8/2013  More...
DBV Technologies Completes Enrollment of Phase IIb VIPES Study, the First-Ever Global Trial in Desensitization to Peanut Allergy 7/8/2013  More...
ERYtech Pharma Announces Fast Take-off of Its Phase IIb Study in Acute Myeloid Leukemia 7/8/2013  More...
Array BioPharma, Inc. (ARRY) Initiates MEK162 Phase 3 MILO Study Triggering Milestone Payment 7/2/2013  More...
Roche (RHHBY)'s Perjeta on US Fast-Track for Early Breast Cancer 7/2/2013  More...
Karolinska Development AB: Pergamum Reports Positive Follow-Up Data From a Phase II Clinical Trial of PXL-01 for Prevention of Post-Surgical Adhesions 6/27/2013  More...
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients 6/26/2013  More...
Prima Biomed (PRR.AX) to Move Forward With Phase 2 Clinical Program for CVac™ in Pancreatic, Colorectal, and Triple-Negative Breast Cancers 6/25/2013  More...
DBV Technologies: Viaskin Peanut Demonstrates Strong Efficacy Trend in Severely Peanut-Allergic Children in 18-Month Results of ARACHILD Pilot Study 6/21/2013  More...
Celgene International Sárl (CELG) Two Studies Evaluating the Combination of REVLIMID® and rituximab in Non-Hodgkin’s Lymphomas Presented at International Conference on Malignant Lymphoma 6/20/2013  More...
PRANA Biotechnology (PRAN) Presents New Benchmark Test to Assess Huntington's Disease Patients in Clinical Trials 6/19/2013  More...
Pluristem Therapeutics (PSTI) Provides Update on Clinical Status of IC Trials 6/19/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Seattle Genetics, Inc. (SGEN) Highlight Post-Hoc Analysis Examining Progression-free Survival With ADCETRIS® (brentuximab vedotin) Versus Prior Therapy at the International Conference on Malignant Lymphoma 6/19/2013  More...
Gilead Sciences, Inc. (GILD) Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin's Lymphoma 6/17/2013  More...
Celgene International Sárl (CELG)'s Apremilast Improves Oral Ulcer Pain From Behcet's Disease 6/14/2013  More...
Eli Lilly and Company (LLY), Incyte Corporation (INCY) Arthritis Pill Effective in Mid-Stage Study 6/13/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) and Active Biotech AB (BTPC) Report Positive Results From Phase IIa Study of Laquinimod in Active Lupus Nephritis 6/12/2013  More...
Biota Pharmaceuticals Initiates Phase 2 Trial of Laninamivir Octanoate for the Treatment of Influenza in Adults 6/12/2013  More...
ViroPharma Incorporated (VPHM) Receives Orphan Drug Designation for Maribavir in Europe 6/11/2013  More...
Bionomics Limited (BMICY.PK) Completes Enrollment for BNC105 Phase II Renal Cancer Trial 6/11/2013  More...
Trigemina Initiates Phase II Clinical Trial of TI-001 for Chronic Migraine 6/10/2013  More...
BrainStorm Cell Therapeutics Inc. Treats 8th Patient in Phase IIa Trial; Completes Enrollment of Final 4 Patients 6/10/2013  More...





 

//-->